Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

about

Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

Item

http://www.wikidata.org/entity/Q55115766

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Severe cutaneous adverse react ...... therapies and immunotherapies.

@en

Severe cutaneous adverse react ...... therapies and immunotherapies.

@nl

type

Item

label

Severe cutaneous adverse react ...... therapies and immunotherapies.

@en

Severe cutaneous adverse react ...... therapies and immunotherapies.

@nl

prefLabel

Severe cutaneous adverse react ...... therapies and immunotherapies.

@en

Severe cutaneous adverse react ...... therapies and immunotherapies.

@nl

P1476

Severe cutaneous adverse react ...... therapies and immunotherapies

@en

P2093

Chan-Keng Yang

http://www.w3.org/2001/XMLSchema#string

Chau Yee Ng

http://www.w3.org/2001/XMLSchema#string

Chen-Yang Huang

http://www.w3.org/2001/XMLSchema#string

Chih-Hsun Yang

http://www.w3.org/2001/XMLSchema#string

Chun-Wei Lu

http://www.w3.org/2001/XMLSchema#string

Jennifer Wu

http://www.w3.org/2001/XMLSchema#string

Meng-Ting Peng

http://www.w3.org/2001/XMLSchema#string

Ming-Ying Wu

http://www.w3.org/2001/XMLSchema#string

Pei-Han Kao

http://www.w3.org/2001/XMLSchema#string

Rosaline Chung-Yee Hui

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme

Skin rash could predict the response to EGFR tyrosine kinase inhibitor and the prognosis for patients with non-small cell lung cancer: a systematic review and meta-analysis

Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response.

Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia

The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

A method for estimating the probability of adverse drug reactions

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

Multikinase Inhibitor-Induced Hand-Foot Skin Reaction: A Review of Clinical Presentation, Pathogenesis, and Management.

Imatinib: a breakthrough of targeted therapy in cancer.

P304

1259-1273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/CMAR.S163391

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chun-Bing Chen

P577

2018-05-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29844705

http://www.w3.org/2001/XMLSchema#string

P932

5962313

http://www.w3.org/2001/XMLSchema#string